Washington Health Policy Week in Review

Washington Health Policy Week in Review is a weekly newsletter that offers selected stories from the daily newsletter CQ HealthBeat.

Analysis Finds Higher Prices, Fewer Drug Choices for Medicare Beneficiaries

Many Medicare beneficiaries will have fewer drugs to choose from next year and will pay more for them, according to a new analysis from the health care consulting firm Avalere Health.

Baucus Outlines Health Care Plan

Max Baucus, the head of the powerful Senate Finance Committee, laid down a marker on a health care overhaul, declaring his independence from other power brokers and signaling that Congress would not wait for the new president to move forward on the issue.

HHS Transition Team Leaders Named

One former House staffer and one former Clinton administration official became the latest to be tapped to manage the Obama administration's transition activities for the Department of Health and Human Services.

Stark Sees Passing Vetoed SCHIP Measure as First Priority

First up on the Ways and Means health agenda next year will be "deferred maintenance"--passing measures opposed or neglected by the Bush administration such as the State Children's Health Insurance Program expansion vetoed by the White House--and "rebasing" physician spending in Medicare to eliminate the need for costly temporary payment patches. So said Ways and Means Health Subcommittee Chairman Pete Stark, D-Calif., in a press briefing laying out the subcommittees' health care agenda for next year.

Study: U.S. Patients More Likely to Call for Health Care Overhaul

Medical patients in the United States are significantly more likely to call for an overhaul of their country's health care system than patients elsewhere in the world, according to findings released by the Commonwealth Fund.

Witnesses Urge $50 Billion Boost in Federal Medicaid Outlays

Gene Sperling, who served as a top economic adviser in the Clinton White House, joined with Gov. Janet Napolitano, D-Ariz., and other governors in calling for an increase of $40 to $50 billion over a two-year period in federal Medicaid spending. But two other witnesses who also testified at the hearing by the House Energy and Commerce Health Subcommittee differed with Sperling and Napolitano over adding Medicaid money to a new economic stimulus package.